Hepatitis B Virus Infections Among Children and Adolescents in Germany: Migration Background as a Risk Factor in a Low Seroprevalence Population

  title={Hepatitis B Virus Infections Among Children and Adolescents in Germany: Migration Background as a Risk Factor in a Low Seroprevalence Population},
  author={Wei Cai and Christina Poethko-M{\"u}ller and Osamah Hamouda and Doris Radun},
  journal={The Pediatric Infectious Disease Journal},
Background: Data on hepatitis B (HB) infection prevalence among children and adolescents in Germany are scarce. We estimated seroprevalence of HB infection and assessed determinants for HB infection among children and adolescents in Germany from a representative population sample. Methods: From 2003 to 2006, the Robert Koch Institute conducted a nationwide cross-sectional Health Interview and Examination Survey for Children and Adolescents in Germany. Data on age, gender, migration background… 

A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities.

  • J. HaussigS. Nielsen R. Zimmermann
  • Medicine
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
  • 2018

Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation

It is concluded that universal HBV vaccination has achieved overall high levels of vaccine-induced immunity, despite regional variations, which may give rise to pockets of susceptible young adults in the future.

Changing epidemiology of hepatitis B and migration--a comparison of six Northern and North-Western European countries.

The study aims were to determine the impact of the migration status on HBV infection by comparing the available data on prevalence and transmission routes of Hepatitis B in the migration and the general population in the six countries; to recommend sensible indicators and pertinent measures forHBV infection surveillance and control in the region.

Vaccine-Preventable Disease-Associated Hospitalisations Among Migrant and Non-migrant Children in New Zealand

A retrospective cohort study from 2006 to 2015 that linked de-identified data from government sources using Statistic NZ’s Integrated Data Infrastructure to improve the understanding of migrant health found higher hospitalisation rates among children with migrant backgrounds and among those of Pacific ethnicity and those with refugee backgrounds.

Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review

The hepatitis B and C prevalence in the general population in Germany is low, however for some groups evidence was incomplete or missing completely, however more research among at-risk groups is needed.

The epidemiology of Hepatitis B, C and D in Germany: A scoping review

A scoping review of the baseline epidemiological situation in Germany regarding burden of disease, sequelae and care of HBV, HCV and HDV as a reference to monitor the progress of the national VH elimination and to identify further knowledge gaps and research needs was performed.

Hepatitis B virus infection in children

For two decades, hepatitis B vaccine has been integrated into national routine childhood vaccination programs in almost all countries. The prevalence of HBsAg has decreased in children worldwide.

Do fathers care about their own immunisation status? The Child-Parent-Immunisation Survey and a review of the literature.

As healthcare personnel have been shown to have the strongest impact on vaccination uptake, it is proposed that this group be further sensitised and educated with the goal of improving immunisation rates in fathers of young children.

Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe

The overall evidence base on HBV and HCV testing has considerable gaps in terms of the countries and populations represented and validity of testing uptake data and more research is needed to guide efforts to provide testing to certain key populations.



Hepatitis B Virus Screening for Internationally Adopted Children

The data reinforce the American Academy of Pediatrics recommendations regarding hepatitis B virus screening and infection control measures for international adoptees and highlight the need for repeat testing 6 months after arrival in the United States.

Natural History of Chronic Hepatitis B Virus Infection in Children of Different Ethnic Origins: A Cohort Study with Up to 12 Years' Follow-up in Northern Greece

The majority of children who developed anti-HBe immunity had biochemical remission, and a substantial number of the inactive carriers lost viremia during the observation period of up to 12 y, suggesting the differences in HBeAg(+) status and seroconversion rate among the ethnic groups are related to the time/mode of HBV infection.

Seroprevalence of hepatitis B infection in the Turkish population in Northern Cyprus.

The study shows that universal infant hepatitis B immunization has a substantial impact on the immunity in children, however, prevalence of HBV infection is still high in adolescent and young adults in Northern Cyprus, therefore, catch-up immunization for these groups will help to reduce hepatitis B transmission.

Hepatitis B Virus Infection in Native versus Immigrant or Adopted Children in Italy Following the Compulsory Vaccination

HBV is not frequent in Italian children today, but it is common among children comming from highly endemic areas, and the vaccination of nonimmune native populations must be strongly recommended.

Hepatitis B in children in Italy: Incidence and risk factors

Surgical interventions, dental therapy and household contacts with a HBsAg chronic carrier were found to be associated with acute hepatitis B.

[Does migration from high and intermediate endemic regions increase the prevalence of hepatitis B infection in Germany?].

These remarkable differences in prevalence make it important that migrants and their close contacts be vaccinated properly, pregnant women be included in screening programs and cases of chronic hepatitis B be treated adequately.

Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.

  • C. WeinbaumI. Williams J. Ward
  • Medicine
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports
  • 2008
Routine testing for HBsAg now is recommended for additional populations withHBsAg prevalence of >/=2%: persons born in geographic regions with HBs Ag prevalence, men who have sex with men, and injection-drug users.

[Vaccination coverage and predictors for vaccination level. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)].

The average prevalence of full immunisation for tetanus, diphia und polio as well as the coverage for the first dose of measles, mumps and rubella (MMR) vaccination was above 90% in children aged 2-17 years.

Seroprevalence and risk factors for hepatitis A, B, and C among roma and non‐roma children in a deprived area of Athens, Greece

Unfavorable living conditions, frequent residency change, lack of child insurance and primary healthcare delivery were significantly associated with seroprevalence of HBV infection among Romas, and general vaccination for HAV, early in life is called for.